Medical Developments International (MDI)
Jay Vaishnav has extensive experience in regulatory affairs and quality management within the medical devices and healthcare sectors. Currently serving as the Regulatory Affairs Manager and Team Lead for Devices at Medical Developments International (MDI) since September 2021, Jay previously held roles at 4DMedical, Parker Healthcare, and Devondale Murray Goulburn, focusing on quality and regulatory compliance. Educationally, Jay holds a Master of Science and a Bachelor in Good Manufacturing Practice and Pharmacy from Swinburne University of Technology, along with a Bachelor in Pharmacy from Barkatullah University and a Diploma in Pharmacy from M.N. College of Pharmacy.
This person is not in the org chart
Medical Developments International (MDI)
"Delivering emergency medical solutions dedicated to improving patient outcomes" Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971. MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia. MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia. MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.